Jump to content

JoyG

Members
  • Posts

    52
  • Joined

  • Last visited

  • Days Won

    1
  • Country

    United States

Everything posted by JoyG

  1. The conclusion of the Association Bulletin only states that an assessment of the role of point-of-issue bacterial screening should be performed at the local facility with medical staff involvement because detailed case mix and platelet logistics requires an in-depth understanding of local operations. Currently our facility is not performing any point-of-issue testing. We are testing our donor apheresis units using the eBDS. We decided that there are logistical issues with using Verax and performing point-of-issue testing at our facility. I think as long as you have documentation of your assessment of this role, the decision is up to the facility and the Medical Director.
  2. Standard 5.13.5 in the 27th is Comparison of patient's previous test results for ABO group and Rh type in last 12 months if comparison is not performed electronically. That retention was 5 years however standard 5.13.5.2 for Difficulty in typing, clinically significant antibodies; etc was indefinite. In the 28th edition, 5.13.5 includes reviewing historical records for the following ABORh, difficulty in typing, clinically sig ab, significant adverse event and special transfusion requirements (merging std 5.13.5, 5.13.5.1, and 5.13.5.2 together). The new record retention period was changed in the 28th edition on Nov 1st to 10 years. Hope that helps!
×
×
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.